SYNC News and Press, Synacor Inc. From 08/12/20

Synacor (NASDAQ: SYNC ) reports Q2 results that missed revenue estimates. Q2 highlights: Revenue was down 43% y/y to $18.2M. Revenue by segment: Software & Services segment totaled $10.9M (+3% y/y), Portal & Advertising totaled $7.3M (-65.8% Y/Y). Adjusted EBITDA margins ex...

Synacor, Inc. (SYNC) Q2 2020 Results Earnings Conference Call August 11, 2020, 5:00 pm ET Company Participants Rob Fink - Investor Relations, Managing Partner at FNK IR Himesh Bhise - Chief Executive Officer Tim Heasley - Chief Financial Officer Conference Call Participants ...

Synacor (NASDAQ: SYNC ) : Q2 Non-GAAP EPS of -$0.07; GAAP EPS of -$0.08 beats by $0.01 . More news on: Synacor, Inc., Earnings news and commentary, Tech stocks news, , Read more ...

Company Announces $10 million Cost Reduction Plan Synacor, Inc. (Nasdaq: SYNC), a leading provider of cloud-based Collaboration and Identity Management software and services serving global enterprises, video, internet and communications providers, and governments, today announced it...

AnPac Bio-Medical Science (NASDAQ: ANPC ) +112% . on validating approved COVID-19 antibody test. More news on: AnPac Bio-Medical Science Co., Ltd., Huttig Building Products, Inc., Plus Therapeutics, Inc., , Read more ...

Synacor, Inc. (Nasdaq: SYNC), the trusted technology, multiplatform services and revenue partner for video, internet and communications providers, device manufacturers, governments and enterprises, today announced it will host a conference call to discuss its second quarter results on Tuesday...

Synacor (NASDAQ: SYNC )  -6%  AH and Qumu (NASDAQ: QUMU ) announced their mutual decision to terminate the earlier proposed all-stock merger agreement on Feb 11. More news on: Qumu Corporation, Synacor, Inc., Tech stocks news, Merger & acquisition news, Read more ...

Synacor, Inc. (Nasdaq: SYNC), a leading provider of cloud-based Collaboration and Identity Management software and services serving global enterprises, video, internet and communications providers, and governments, and Qumu Corporation (Nasdaq: QUMU) a leading provider of tools to create, man...

Merger activity decreased last week with one new deal announced, two deals closing, and one deal called off. After terminating deals with AcelRx Pharmaceuticals (ACRX) and Melinta Therapeutics (MLNT), Tetraphase Pharmaceuticals (TTPH) agreed to be acquired by La Jolla Pharmaceutical Company ...

Merger activity remained stuck in neutral last week with no new deals announced and no deals closing. We did have one deal enter into litigation, and arbitrageurs are watching it closely to see if the courts can force the acquiring company to close the deal on the original terms. There were ...